Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus

Atherosclerosis

Volumn 203, Issue 2, 2009, Pages 522-527

  Shiu, Sammy W M ^a   Tan, Kathryn C B ^a   Wong, Ying ^a   Leng, Lin ^b   Bucala, Richard ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glycoxidized LDL; Lectin like oxidized low density lipoprotein receptor; N (carboxymethyl)lysine; Oxidized LDL; Type 2 diabetes

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ACETYL LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN B; GLYCATED LOW DENSITY LIPOPROTEIN; GLYCOXIDIZED LOW DENSITY LIPOPROTEIN; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; CULTURE MEDIUM; DIABETIC PATIENT; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; GROUPS BY AGE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION;

ADULT; AGED; ALBUMINURIA; APOLIPOPROTEINS B; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOSYLATION; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; SCAVENGER RECEPTORS, CLASS E;

EID: 62649164710     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.07.012     Document Type: Article

References (26)

1. Chisolm G.M., and Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 28 (2000) 1815-1826
2. Veiraiah A. Hyperglycemia, lipoprotein glycation, and vascular disease. Angiology 56 (2005) 431-438
3. Hunt J.V., Smith C.C., and Wolff S.P. Autooxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39 (1990) 1420-1424
4. Kawamura M., Heinecke J.W., and Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest 94 (1994) 771-778
5. Sakata N., Uesugi N., Takebayashi S., et al. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis. Cardiovasc Res 49 (2001) 466-475
6. Imanaga Y., Sakata N., Takebayashi S., et al. In vivo and in vitro evidence for the glycosylation of low-density lipoprotein in human atherosclerotic plaques. Atherosclerosis 150 (2000) 343-355
7. Graessler J., Pietzsch J., Westendorf T., Julius U., Bornstein S.R., and Kopprasch S. Glycoxidized LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator-activator receptor γ gene expression in macrophages. Diabetologia 50 (2007) 1080-1088
8. Bucala R., Makita Z., Vega G., et al. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci 91 (1994) 9441-9445
9. Velarde V., Jenkins A.J., Christopher J., Lyons T.J., and Jaffa A.A. Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells. J Appl Physiol 91 (2001) 1412-1420
10. Calzada C., Coulon L., Halami D., et al. In vitro glycoxidized low density lipoproteins and low density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase. J Clin Endocrinol Metab 92 (2007) 1961-1964
11. Sonoki K., Yoshinari M., Iwase M., et al. Glycoxidized low-density lipoprotein enhances monocyte chemoattractant protein-1 mRNA expression in human umbilical vein endothelial cells: relation to lysophosphatidylcholine contents and inhibition by nitric oxide donor. Metabolism 51 (2002) 1135-1142
12. Napoli C., Lerman L., de Nigris F., Loscalzo J., and Ignarro L.J. Glycoxidized low-density lipoprotein downregulates endothelial nitric oxide synthase in human coronary cells. J Am Coll Cardiol 40 (2002) 1515-1522
13. Lam M.C., Tan K.C., and Lam K.S. Glycoxidized low density lipoprotein regulates the expression of scavenger receptors in THP-1 macrophages. Atherosclerosis 177 (2004) 313-320
14. Mehta J.L., Chen J., Hermonat P.L., Romeo F., and Novelli G. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 69 (2006) 36-45
15. Hayashida K., Kume N., Murase T., et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation 112 (2005) 812-818
16. Zuckerman S.H., and Bryan N. Inhibition of LDL oxidation and myeloperoxidase dependent tyrosyl radical formation by the selective estrogen receptor modulator raloxifene. Atherosclerosis 126 (1996) 65-75
17. Wagner Z., Wittmann I., Mazák I., et al. N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function. Am J Kidney Dis 38 (2001) 785-791
18. Tan K.C., Shiu S.W., Wong Y., Leng L., and Bucala R. Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus. J Lipid Res 49 (2008) 1438-1444
19. Stitt A.W., He C., Friedman S., et al. Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med 3 (1997) 617-627
20. Mehta J.L., and Li D.Y. Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun 248 (1998) 511-514
21. Aoyama T., Fujiwara H., Masaki T., and Sawamura T. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. J Mol Cell Cardiol 31 (1999) 2101-2114
22. Chen M., Nagase M., Fujita T., Narumiya S., Masaki T., and Sawamura T. Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and AGE. Biochem Biophys Res Commun 287 (2001) 962-968
23. Jono T., Miyazaki A., Nagai R., Sawamura T., Kitamura T., and Horiuchi S. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett 511 (2002) 170-174
24. Holvoet P., Donck J., Landeloos M., et al. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost 76 (1996) 663-669
25. Vohra R.S., Murphy J.E., Walker J.H., Ponnambalam S., and Homer-Vanniasinkam S. Atherosclerosis and the lectin-like oxidized low-density lipoprotein scavenger receptor. Trends Cardiovasc Med 16 (2006) 60-64
26. Li L., Sawamura T., and Renier G. Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes 52 (2003) 1843-1850